The -351A/G polymorphism of ESR1 is associated with risk of myocardial infarction but not with extreme longevity

Clinica Chimica Acta

Volumn 411, Issue 23-24, 2010, Pages 1883-1887

  Roszkowska Gancarz, Malgorzata ^a   Kurylowicz, Alina ^b   Polosak, Jacek ^a   Ambroziak, Michal ^a   Puzianowska Kuznicka, Monika ^a,b  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Centenarians; Estrogen receptor gene (ESR1); Longevity; Myocardial infarction (MI); Polymorphism

Indexed keywords

CHOLESTEROL; ESTROGEN RECEPTOR ALPHA; GENOMIC DNA; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HEART INFARCTION; HUMAN; LONGEVITY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; ADULT; AGED, 80 AND OVER; CASE-CONTROL STUDIES; ESTROGEN RECEPTOR ALPHA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LONGEVITY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 77957753400     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.06.028     Document Type: Article

References (35)

1. Teriokhin A.T., Budilova E.V., Thomas F., Guegan J.F. Worldwide variation in life-span sexual dimorphism and sex-specific environmental mortality rates. Hum Biol 2004, 76:623-641.
2. Mossakowska M., Barcikowska M., Broczek K., et al. Polish centenarians programme. Multidisciplinary studies of successful ageing: aims, methods, and preliminary results. Exp Gerontol 2008, 43:238-244.
3. Martelin T., Mäkelä P., Valkonen T. Contribution of deaths related to alcohol or smoking to the gender difference in life expectancy: Finland in the early 1990s. Eur J Public Health 2004, 14:422-427.
4. Eskes T., Haanen C. Why do women live longer than men?. Eur J Obstet Gynecol Reprod Biol 2007, 133:126-133.
5. Viña J., Sastre J., Pallardó F.V., Gambini J., Borrás C. Role of mitochondrial oxidative stress to explain the different longevity between genders: protective effect of estrogens. Free Radic Res 2006, 40:1359-1365.
6. Viña J., Sastre J., Pallardó F.V., Gambini J., Borrás C. Modulation of longevity-associated genes by estrogens or phytoestrogens. Biol Chem 2008, 389:273-277.
7. Simpson E.R. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003, 86:225-230.
8. Couse J.E., Mahato D., Eddy E.M., Korach K.S. Molecular mechanism of estrogen action in the male: insights from the estrogen receptor null mice. Reprod Fertil Dev 2001, 13:211-219.
9. Lambard S., Carreau S. Aromatase and oestrogens in human male germ cells. Int J Androl 2005, 28:254-259.
10. Matthews J., Gustafsson J.A. Estrogen signaling: a subtle balance between ERα and ERβ. Mol Interv 2003, 3:281-292.
11. Björnström L., Sjöberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 2005, 19:833-842.
12. Cheskis B.J., Greger J.G., Nagpal S., Freedman L.P. Signaling by estrogens. J Cell Physiol 2007, 213:610-617.
13. Li L., Haynes M.P., Bender J.R. Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA 2003, 100:4807-4812.
14. Yang S.H., Liu R., Perez E.J., et al. Mitochondrial localization of estrogen receptor β. Proc Natl Acad Sci USA 2004, 101:4130-4135.
15. Nilsson S., Gustafsson J.A. Biological role of estrogen and estrogen receptors. Crit Rev Biochem Mol Biol 2002, 37:1-28.
16. Kannel W.B. The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women. J Gend.-Specif Med 2002, 5:27-37.
17. Sumi D., Ignarro L.J. Estrogen-related receptor α 1 up-regulates endothelial nitric oxide synthase expression. Proc Natl Acad Sci USA 2003, 100:14451-14456.
18. Figtree G.A., McDonald D., Watkins H., Channon K.M. Truncated estrogen receptor α 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase. Circulation 2003, 107:120-126.
19. Karim R., Hodis H.N., Stanczyk F.Z., Lobo R.A., Mack W.J. Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab 2008, 93:131-138.
20. Manson J.E., Allison M.A., Rossouw J.E., et al. Estrogen therapy and coronary artery calcification. New Engl J Med 2007, 356:2591-2602.
21. Grady D., Herrington D., Bittner V., et al. Cardiovascular disease outcomes during 6.8years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002, 288:49-57. HERS Research Group.
22. Pérez-López F.R., Chedraui P., Gilbert J.J., Pérez-Roncero G. Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women's Health Initiative era. Fertil Steril 2009, 92:1171-1186.
23. Lobo R.A. The risk of stroke in postmenopausal women receiving hormonal therapy. Climacteric 2009, 12(Suppl 1):81-85.
24. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988, 16:1215.
25. Schuit S.C., van Meurs J.B., Bergink A.P., et al. Height in pre- and postmenopausal women is influenced by estrogen receptor α gene polymorphisms. J Clin Endocrinol Metab 2004, 89:303-309.
26. Shearman A.M., Demissie S., Cupples L.A., et al. Tobacco smoking, estrogen receptor α gene variation and small low density lipoprotein level. Hum Mol Genet 2005, 14:2405-2413.
27. Schuit S.C., Oei H.H., Witteman J.C., et al. Estrogen receptor α gene polymorphisms and risk of myocardial infarction. JAMA 2004, 291:2969-2977.
28. Molvarec A., Nagy B., Kovács M., et al. Lipid, haemostatic and inflammatory variables in relation to the estrogen receptor α (ESR1) PvuII and XbaI gene polymorphisms. Clin Chim Acta 2007, 380:157-164.
29. Rokach A., Pollak A., Rosen L., et al. Estrogen receptor α gene polymorphisms are associated with the angiographic extent of coronary artery disease. J Clin Endocrinol Metab 2005, 90:6556-6560.
30. Koch W., Hoppmann P., Pfeufer A., Mueller J.C., Schömig A., Kastrati A. No replication of association between estrogen receptor α gene polymorphisms and susceptibility to myocardial infarction in a large sample of patients of European descent. Circulation 2005, 112:2138-2142.
31. Shearman A.M., Cooper J.A., Kotwinski P.J., et al. Estrogen receptor α gene variation is associated with risk of myocardial infarction in more than seven thousand men from five cohorts. Circ Res 2006, 98:590-592.
32. Feise R.J. Do multiple outcome measures require p-value adjustment?. BMC Med Res Methodol 2002, 2:8.
33. Guolo A. Robust techniques for measurement error correction: a review. Stat Meth Med Res 2008, 17:555-580.
34. Koretz R.L. Is statistical significance always significant?. Nutr Clin Pract 2005, 20:303-307.
35. Hopewell S., Loudon K., Clarke M.J., Oxman A.D., Dickersin K. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev 2009, 1:MR000006.